The reduction in price target by a significant margin from Goldman Sachs, a major financial institution, suggests a bearish outlook on Zevia's short-term price potential. This adjustment reflects concerns or adjustments in the company's valuation or expected performance, which could lead to decreased investor confidence and a potential decrease in stock price in the short term.